" /> BET Inhibitor ABBV-744 - CISMeF





Preferred Label : BET Inhibitor ABBV-744;

NCIt synonyms : BD2-selective BET Inhibitor ABBV-744;

NCIt related terms : ABBV-744;

NCIt definition : An orally bioavailable inhibitor of the Bromodomain and Extra-Terminal (BET) family of proteins, with potential antineoplastic activity. Upon oral administration, the BET inhibitor ABBV-744 preferentially binds to the second bromodomain (BD2) of BET proteins, thereby preventing the interaction between the BET proteins and acetylated histones. This disrupts chromatin remodeling and gene expression. Prevention of the expression of certain growth-promoting genes may lead to an inhibition of proliferation in BET-overexpressing tumor cells. BET proteins, comprised of BRD2, BRD3, BRD4 and BRDT, are transcriptional regulators that contain two homologous bromodomains, the BD1 and BD2 domains. They play an important role during development and cellular growth.;

UNII : 9MX546E2SF;

CAS number : 2138861-99-9; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 2138861-99-9 alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo G-SRS /a ;

Molecule name : ABBV-744; ABBV 744;

NCI Metathesaurus CUI : CL550999;

Details


You can consult :


Nous contacter.
09/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.